Arcturus Therapeutics Holdings Inc (ARCT)
26.16
-0.82
(-3.04%)
USD |
NASDAQ |
Apr 25, 16:00
26.16
0.00 (0.00%)
After-Hours: 17:15
Arcturus Therapeutics Holdings Cash from Operations (TTM): -18.10M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -18.10M |
September 30, 2023 | 142.79M |
June 30, 2023 | 132.79M |
March 31, 2023 | 45.16M |
December 31, 2022 | 31.99M |
September 30, 2022 | -170.76M |
June 30, 2022 | -145.01M |
March 31, 2022 | -141.13M |
December 31, 2021 | -135.04M |
September 30, 2021 | -99.18M |
June 30, 2021 | -98.40M |
March 31, 2021 | -73.95M |
December 31, 2020 | -42.86M |
September 30, 2020 | -43.77M |
June 30, 2020 | -30.73M |
March 31, 2020 | -12.89M |
December 31, 2019 | -6.445M |
September 30, 2019 | -4.67M |
June 30, 2019 | -8.629M |
March 31, 2019 | -25.81M |
December 31, 2018 | -20.76M |
Date | Value |
---|---|
September 30, 2018 | -9.996M |
June 30, 2018 | -4.931M |
March 31, 2018 | 4.143M |
December 31, 2017 | -0.46M |
September 30, 2017 | 6.896M |
June 30, 2017 | 1.951M |
March 31, 2017 | -3.388M |
December 31, 2016 | -2.861M |
September 30, 2016 | 6.941M |
June 30, 2016 | 8.233M |
March 31, 2016 | 8.448M |
December 31, 2015 | 8.29M |
September 30, 2015 | -21.61M |
June 30, 2015 | -25.72M |
March 31, 2015 | -27.29M |
December 31, 2014 | -28.33M |
September 30, 2014 | -25.41M |
June 30, 2014 | -17.91M |
March 31, 2014 | -12.80M |
December 31, 2013 | -7.353M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-170.76M
Minimum
Sep 2022
142.79M
Maximum
Sep 2023
-35.73M
Average
-30.73M
Median
Jun 2020
Cash from Operations (TTM) Benchmarks
AIM ImmunoTech Inc | -21.27M |
Perspective Therapeutics Inc | -36.91M |
Protalix BioTherapeutics Inc | -1.318M |
Electromed Inc | 4.872M |
Armata Pharmaceuticals Inc | -47.42M |